Oncolytics Biotech (ONCY) Enterprise Value Growth (1y) (2010 - 2025)
Oncolytics Biotech (ONCY) Enterprise Value Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.06% |
| Sep 30, 2025 | 37.53% |
| Jun 30, 2025 | 41.90% |
| Mar 31, 2025 | 51.45% |
| Dec 31, 2024 | 52.76% |
| Sep 30, 2024 | 51.83% |
| Jun 30, 2024 | -39.30% |
| Mar 31, 2024 | -87.12% |
| Dec 31, 2023 | -198.38% |
| Sep 30, 2023 | -20.19% |
| Jun 30, 2023 | 50.64% |
| Mar 31, 2023 | 62.34% |
| Dec 31, 2022 | 73.75% |
| Sep 30, 2022 | 35.05% |
| Jun 30, 2022 | 36.06% |
| Mar 31, 2022 | 21.66% |
| Dec 31, 2021 | -36.69% |
| Sep 30, 2021 | -43.02% |
| Jun 30, 2021 | -38.16% |
| Dec 31, 2020 | -123.45% |